Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Replimune Inc.
Replimune Inc.
Revolution Medicines, Inc.
Celldex Therapeutics
National Cancer Institute (NCI)
Revolution Medicines, Inc.
IGF Oncology, LLC
University of Illinois at Chicago